Lung Diseases

21st Annual Congress on Neonatal and Pediatric Nursing

September 7, 2018

Theme: Milestones in Neonatal and Pediatric Nursing

World’s first hand-held infrared devices for COPD and other conditions to be produced following Glyconics agreement with Spectrolytic

August 3, 2018

A hand-held device that would give early warning of ‘acute events’, and so avoid the hospitalisation of thousands of patients with chronic obstructive pulmonary disease (COPD), is to go into production ahead of clinical trials. This follows an agreement between medical diagnostics company Glyconics and Spectrolytic, a leading developer of infrared (IR) spectrometers. IR spectrometry […]

Sunovion Announces Data Presentations Highlighting Broad Portfolio of Treatments for COPD at the American Thoracic Society International Conference 2018

May 16, 2018

– Poster presentations focus on clinical studies of a range of nebulized and handheld therapies for chronic obstructive pulmonary disease (COPD)  – New data analyses highlight effects on lung function and patient-reported outcomes for Seebri ® Neohaler ® (glycopyrrolate) Inhalation Powder and Utibron ® Neohaler ® (indacaterol/glycopyrrolate) Inhalation Powder – Sunovion Pharmaceuticals Inc. (Sunovion) will present […]

Amneal Gains Approval for Erythromycin Tablets USP

March 14, 2018

Amneal Pharmaceuticals has received FDA approval for Erythromycin Tablets USP, 250 mg and 500 mg strengths.  The Amneal product is a therapeutic equivalent for the reference listed drug (RLD) Erythromycin Tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet available. “Amneal is committed to increasing access to affordable medications,” said Amneal […]

ERT Expands Respiratory Solutions to Support New Endpoints

February 8, 2018

ERT Expands Respiratory Solutions to Support New Endpoints Industry-leading MasterScope™ integration provides centralized Forced Oscillation Technique services to deliver high quality data while lessening patient and site burden PHILADELPHIA – February 8, 2018 – ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced advanced respiratory clinical trial […]

Asthma & COPD

November 27, 2017

Comprehend Systems Appoints New CEO in Response to Surging Demand for Clinical Intelligence Solutions; Enterprise Growth Expert to Scale Company and Expand Partner Ecosystem

November 20, 2017

Redwood City, Calif., November 13, 2017—Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, has named Terry Cunningham CEO.  Cunningham will focus on scaling Comprehend in response to explosive customer demand for solutions that reduce time and risk in clinical trials. Cunningham will also drive expanded partner programs to help sponsors achieve faster, better clinical […]

Asana BioSciences to Present Updates on its Oncology Development Pipeline at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 25, 2017

Asana BioSciences, LLC, an oncology focused, clinical stage biopharmaceutical company, today announced that it will present updates regarding three of its lead molecules at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Philadelphia, PA, October 26-30, 2017. “We are very pleased with the progress made in advancing our oncology […]

FEEDBACK